A Colorado State University (Fort  Collins, CO, 

) research  team has developed a novel vaccine to prevent tuberculosis (TB). The vaccine  triggers the body’s immunity in a novel way by activating specific immune  system functions that enhance the response to the bacterium that causes  tuberculosis. Although in preliminary stages of testing, the vaccine would  likely be effective against all strains of TB, including multidrug and  extensively drug-resistant tuberculosis. Preliminary evidence shows that the  vaccine has promise of working after exposure to TB, which no other vaccine in  current development has achieved. The vaccine is designed to be relatively easy  to produce. Human trials for the vaccine could occur in two to three years.

News

A Colorado State University (Fort Collins, CO, www.colostate.edu) research team has developed a novel vaccine to prevent tuberculosis (TB).